Molecular Assemblies Closes Oversubscribed $24 Million Series A Financing to Advance Enzymatic DNA Synthesis toward Initial Commercial Access
Q1 Shatters Previous Synthetic Biology Investment Record – Signals Projected 2021 Investment of up to $36 Billion
Amyris And DSM Close Significant Strategic Transaction To Accelerate The Growth Of Natural, Sustainable Ingredients
Ecovative Propels Commercial Scale Mycelium Applications for Textiles, Packaging, and Food with new $60M Series D Financing led by Viking Global Investors
